4SC AG said U.S. regulators granted orphan drug status to the experimental Hodgkin’s Lymhoma drug Resminostat.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000